Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer

Gerwin Heller1, Joseph Geradts, Barbara Ziegler

  • 1Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Insights

Tumor suppressor genes TSLC1 and DAL-1 are frequently inactivated by methylation in breast cancer, impacting cell adhesion and tumor progression. Methylation levels correlate with higher tumor grade and loss of hormone receptor expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • TSLC1 and DAL-1 are tumor suppressor genes crucial for cell adhesion.
  • Altered expression and methylation of these genes are implicated in various cancers.

Purpose of the Study:

  • To investigate the expression and methylation patterns of TSLC1 and DAL-1 in breast cancer.
  • To determine the correlation between gene inactivation and clinicopathological features of breast cancer.

Main Methods:

  • Analysis of TSLC1 and DAL-1 expression and methylation in breast cancer cell lines and primary tumors.
  • Treatment of breast cancer cells with demethylating agents (5-aza-2'-deoxycytidine and TSA) to assess gene re-expression.
  • Correlation analysis with tumor grade and hormone receptor status (ER, PgR).

Main Results:

  • Loss of TSLC1 and DAL-1 expression was frequent in breast cancer cell lines and primary tumors.
  • Methylation was observed in a significant proportion of breast cancer samples, correlating with gene silencing.
  • Demethylation treatment led to re-expression of TSLC1 and DAL-1.
  • TSLC1 and/or DAL-1 methylation was more frequent in high-grade (grade 3) tumors.
  • TSLC1 methylation correlated with the loss of Estrogen Receptor (ER) and Progesterone Receptor (PgR) staining.

Conclusions:

  • TSLC1 and DAL-1 are frequently inactivated by promoter methylation in breast cancer.
  • Gene methylation is a significant mechanism contributing to the loss of these tumor suppressors in breast cancer pathogenesis.
  • Methylation of TSLC1 and DAL-1 may serve as potential biomarkers for aggressive breast cancer subtypes.

Related Concept Videos

Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.5K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

No description available
4.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.5K